Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Greece

Research and Innovation Action · Running

DIOPTRA Early Dynamic Screening for Colorectal Cancer via Novel Protein Biomarkers Reflecting Biological Initiation Mechanisms

Coordinator
Erevnitiko Panepistimiako Institouto Systimaton Epikoinonion Kai Ypologiston, Greece
Runs
1 January 2023 to 31 December 2026
Status
Running
EU funding
€13.6m
Total cost
€13.6m
Partners
30 organisations in 16 countries
Type
Research and Innovation Action
Grant agreement
101096649

What the project is doing

In the project's own words, from its summary on CORDIS.

DIOPTRA aims to introduce a front-line screening tool that will consider risk factors and protein biomarkers for pinpointing individuals at a high risk for colorectal cancer (CRC) incidence. Tissue & blood samples will be examined towards a discriminative set of prognostic proteins that are detectable via standard bloodwork and can indicate a need for further evaluation (i.e. colonoscopy). Other data (e.g. medical, behavioural) will also be considered as potential risk factors.

Artificial intelligence (AI) will be leveraged for assessing prognostic power, while personalised behavioural change will be promoted based on modifiable risk factors. Given the low citizen participation on CRC screening across EU, DIOPTRA seeks to broaden the evaluated population, boosting participation rates and bypassing age screening thresholds. This action is part of the Cancer Mission cluster of projects on ‘Prevention, including Screening’.

Who is involved

OrganisationCityCountryRole
Erevnitiko Panepistimiako Institouto Systimaton Epikoinonion Kai YpologistonAthinaGreeceCoordinator
Medizinische Universitat GrazGrazAustriaParticipant
Ainigma TechnologiesLeuvenBelgiumParticipant
Centre Hospitalier Universitaire De LiegeLiegeBelgiumParticipant
European Hospital and Healthcare FederationBruxelles / BrusselBelgiumParticipant
Bloks Zdravni I Sotsialni Grizhi EoodSofiaBulgariaParticipant
Martel GmbHDubendorfSwitzerlandAssociatedpartner
Sphynx Technology Solutions AGZugSwitzerlandAssociatedpartner
Cscy Computer Solutions Cyprus LtdNicosiaCyprusParticipant
Csi Center for Social Innovation LtdNicosiaCyprusParticipant
Linac-Pet Scan Opco LimitedLimassolCyprusParticipant
Vilabs (cy) LtdLimassolCyprusParticipant
Komiteen for SundhedsoplysningKobenhavnDenmarkParticipant
Region MidtjyllandViborgDenmarkParticipant
Region SyddanmarkVejleDenmarkParticipant
D.tsakalidis-G.domalis OePatraGreeceParticipant
Ethniko Kai Kapodistriako Panepistimio AthinonAthinaGreeceParticipant
Geniko Antikarkiniko Ogkologiko Nosokomeio Athinon O Agios SavvasAthinaGreeceParticipant
Panepistimio IoanninonIoanninaGreeceParticipant
Protavio Monoprosopi E.p.eGlyfadaGreeceParticipant
Fundacion Burgos Por La Investigacion De La SaludBurgosSpainParticipant
Klinicka Bolnica DubravaZagrebCroatiaParticipant
I2grow Innovation to Grow SRLMilanoItalyParticipant
Uab TeraglobusVilniusLithuaniaParticipant
Netcompany S.a.LuxembourgLuxembourgParticipant
Smartsol SiaRigaLatviaParticipant
Arthur's Legal BVAmsterdamNetherlandsParticipant
Tecreando B.v.AmsterdamNetherlandsParticipant
Univerzitetni klinicni center MariborMariborSloveniaParticipant
Cambridge Medical Academy LtdCambridgeUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI